Cubist Systematic Strategies’s Intellia Therapeutics NTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-188,316
| Closed | -$3.87M | – | 2043 |
|
|
2024
Q3 | $3.87M | Buy |
+188,316
| New | +$3.87M | 0.02% | 439 |
|
|
2024
Q2 | – | Sell |
-23,159
| Closed | -$637K | – | 2256 |
|
|
2024
Q1 | $637K | Buy |
23,159
+4,117
| +22% | +$113K | ﹤0.01% | 1313 |
|
|
2023
Q4 | $581K | Sell |
19,042
-4,794
| -20% | -$146K | ﹤0.01% | 1324 |
|
|
2023
Q3 | $754K | Buy |
+23,836
| New | +$754K | 0.01% | 1139 |
|
|
2023
Q2 | – | Sell |
-117,395
| Closed | -$4.38M | – | 2772 |
|
|
2023
Q1 | $4.38M | Sell |
117,395
-53,756
| -31% | -$2M | 0.03% | 680 |
|
|
2022
Q4 | $5.97M | Buy |
171,151
+83,784
| +96% | +$2.92M | 0.03% | 572 |
|
|
2022
Q3 | $4.89M | Buy |
87,367
+279
| +0.3% | +$15.6K | 0.03% | 842 |
|
|
2022
Q2 | $4.51M | Buy |
87,088
+75,499
| +651% | +$3.91M | 0.03% | 895 |
|
|
2022
Q1 | $842K | Buy |
+11,589
| New | +$842K | 0.01% | 2168 |
|
|
2021
Q4 | – | Sell |
-20,830
| Closed | -$2.79M | – | 3571 |
|
|
2021
Q3 | $2.79M | Buy |
20,830
+1,733
| +9% | +$232K | 0.04% | 796 |
|
|
2021
Q2 | $3.09M | Buy |
19,097
+16,741
| +711% | +$2.71M | 0.03% | 811 |
|
|
2021
Q1 | $189K | Sell |
2,356
-42,807
| -95% | -$3.43M | ﹤0.01% | 2495 |
|
|
2020
Q4 | $2.46M | Sell |
45,163
-1,495
| -3% | -$81.3K | 0.03% | 821 |
|
|
2020
Q3 | $928K | Sell |
46,658
-13,541
| -22% | -$269K | 0.01% | 1384 |
|
|
2020
Q2 | $1.27M | Buy |
+60,199
| New | +$1.27M | 0.02% | 1053 |
|
|
2019
Q2 | – | Sell |
-10,023
| Closed | -$171K | – | 2547 |
|
|
2019
Q1 | $171K | Sell |
10,023
-43,646
| -81% | -$745K | 0.01% | 1852 |
|
|
2018
Q4 | $733K | Buy |
53,669
+48,175
| +877% | +$658K | 0.03% | 723 |
|
|
2018
Q3 | $157K | Sell |
5,494
-7,159
| -57% | -$205K | 0.01% | 1467 |
|
|
2018
Q2 | $346K | Buy |
12,653
+709
| +6% | +$19.4K | 0.02% | 992 |
|
|
2018
Q1 | $252K | Buy |
+11,944
| New | +$252K | 0.01% | 1262 |
|